Intelligent Bio Solutions Inc
INBS
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.51M
Close$
$-15.56
1037.5% downside
Current Fair Value
1037.5% downsideOvervalued by 1037.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.51 Million |
|---|---|
| Enterprise Value | $3.33 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.44 |
| Beta | 4.25 |
| Outstanding Shares | 2,905,603 |
Return
| Return on Equity | -225.57% |
|---|---|
| Return on Assets | -104.10% |
| Return on Invested Capital | -181.00% |
Valuation & Multiples
| P/E Ratio | -0.18 |
|---|---|
| PEG | -0.66 |
| Price to Sales | 1.66 |
| Price to Book Ratio | 1.66 |
| Enterprise Value to Revenue | 0.79 |
| Enterprise Value to EBIT | -0.26 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.55 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
$-1.58
Average shareholder expectationRevenue Estimate
$1.22 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-1.58
Average shareholder expectationRevenue Estimate
$1.22 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.66%▲ 13.40% |
|---|---|
| Total Invested | $1.38M▲ 13.43% |
| Investors Holding | 12▲ 3.00% |
ESG Score
No data
About Intelligent Bio Solutions Inc
8 employeesGBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and...